30225811000001105: Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)
\UK product\Virtual medicinal product\Atazanavir 300mg / Cobicistat 150mg tablets\Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Atazanavir + Cobicistat\Atazanavir 300mg / Cobicistat 150mg tablets\Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)
\UK product\Trade family\Evotaz\Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing cytochrome P450 inhibitor (product)\Product containing cobicistat\Product containing atazanavir and cobicistat\Atazanavir + Cobicistat\Atazanavir 300mg / Cobicistat 150mg tablets\Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing protease inhibitor\Product containing atazanavir\Product containing atazanavir and cobicistat\Atazanavir + Cobicistat\Atazanavir 300mg / Cobicistat 150mg tablets\Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Product containing carboxylic acid and/or carboxylic acid derivative (product)\Product containing carbamate\Product containing cobicistat\Product containing atazanavir and cobicistat\Atazanavir + Cobicistat\Atazanavir 300mg / Cobicistat 150mg tablets\Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing urea and/or urea derivative (product)\Product containing cobicistat\Product containing atazanavir and cobicistat\Atazanavir + Cobicistat\Atazanavir 300mg / Cobicistat 150mg tablets\Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing atazanavir\Product containing atazanavir and cobicistat\Atazanavir + Cobicistat\Atazanavir 300mg / Cobicistat 150mg tablets\Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing thiazole\Product containing cobicistat\Product containing atazanavir and cobicistat\Atazanavir + Cobicistat\Atazanavir 300mg / Cobicistat 150mg tablets\Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Medicinal product acting as antiretroviral agent (product)\Product containing atazanavir\Product containing atazanavir and cobicistat\Atazanavir + Cobicistat\Atazanavir 300mg / Cobicistat 150mg tablets\Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Sep 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

93966701000001110 Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

93966801000001118 Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator	EMA (European Medicines Agency) monitoring	false	Inferred relationship	Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Is a	Atazanavir 300mg / Cobicistat 150mg tablets	true	Inferred relationship	Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has specific active ingredient	Cobicistat	false	Inferred relationship	Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has specific active ingredient	Atazanavir sulfate	true	Inferred relationship	Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Atazanavir	true	Inferred relationship	Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has active ingredient	Atazanavir	true	Inferred relationship	Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Is a	Evotaz	true	Inferred relationship	Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has specific active ingredient	Cobicistat	true	Inferred relationship	Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has basis of strength substance	Atazanavir	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 30 tablet	Has AMP	True	Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
93966701000001110	Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
93966801000001118	Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module